{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:29:40Z","timestamp":1793975380407,"version":"4.8.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.ijtb.2023.05.012","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T02:57:02Z","timestamp":1684205822000},"page":"S14-S23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S1","title":["An overview of the BCG vaccine and its future scope"],"prefix":"10.1016","volume":"70","author":[{"given":"Pallavi","family":"Khandelia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikha","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8163-355X","authenticated-orcid":false,"given":"Pratichi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.ijtb.2023.05.012_bib1","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2018.03.009","article-title":"BCG vaccine: WHO position paper, February 2018\u2013recommendations","volume":"36","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ijtb.2023.05.012_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MGM2-0028-2013","article-title":"BCG vaccines","volume":"2","author":"Tran","year":"2014","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.ijtb.2023.05.012_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG World Atlas: a database of global BCG vaccination policies and practices","volume":"8","author":"Zwerling","year":"2011","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.ijtb.2023.05.012_bib4","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1186\/s12889-019-7868-9","article-title":"A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities","volume":"19","author":"Faust","year":"2019","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.ijtb.2023.05.012_bib5","unstructured":"WHO. Global reportTuberculosis report 2021. ([Google Scholar])."},{"issue":"8","key":"10.1016\/j.ijtb.2023.05.012_bib6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro1211","article-title":"The success and failure of BCG - implications for a novel tuberculosis vaccine","volume":"3","author":"Andersen","year":"2005","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.ijtb.2023.05.012_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00100-19","article-title":"Tuberculosis vaccine development: progress in clinical evaluation","volume":"33","author":"Sable","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.ijtb.2023.05.012_bib8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/joim.13191","article-title":"Is mapping the BCG vaccine-induced immune responses the key to improving the efficacy against tuberculosis?","volume":"288","author":"Kuan","year":"2020","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.ijtb.2023.05.012_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41591-018-0319-9","article-title":"Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques","volume":"25","author":"Dijkman","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.ijtb.2023.05.012_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tube.2016.09.004","article-title":"Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations","volume":"101","author":"Sharpe","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ijtb.2023.05.012_bib11","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1016\/j.vaccine.2010.07.086","article-title":"WHO informal consultation on standardization and evaluation of BCG vaccines Geneva, Switzerland 22-23 September 2009","volume":"28","author":"Ho","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ijtb.2023.05.012_bib12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/mi.2012.19","article-title":"Mechanisms of delayed anti-tuberculosis protection in the lung of parenteral BCG-vaccinated hosts: a critical role of airway luminal T cells","volume":"5","author":"Horvath","year":"2012","journal-title":"Mucosal Immunol"},{"issue":"7","key":"10.1016\/j.ijtb.2023.05.012_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.it.2010.05.002","article-title":"Airway luminal T cells: a newcomer on the stage of TB vaccination strategies","volume":"31","author":"Jeyanathan","year":"2010","journal-title":"Trends Immunol"},{"issue":"6","key":"10.1016\/j.ijtb.2023.05.012_bib14","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.4049\/jimmunol.1502307","article-title":"BCG vaccination induces robust CD4+ T cell responses to mycobacterium tuberculosis complex\u2013specific lipopeptides in Guinea Pigs","volume":"196","author":"Kaufmann","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.ijtb.2023.05.012_bib15","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.4049\/jimmunol.0801694","article-title":"Antigen Load Governs the Differential Priming of CD8 T Cells in Response to the Bacille Calmette Guerin Vaccine or Mycobacterium tuberculosis Infection","volume":"182","author":"Ryan","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.ijtb.2023.05.012_bib16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2567.2002.01366.x","article-title":"Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies","volume":"105","author":"Hussey","year":"2002","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.ijtb.2023.05.012_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007643","article-title":"A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates","volume":"15","author":"Rodo","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijtb.2023.05.012_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005490","article-title":"TIM3 mediates T cell exhaustion during Mycobacterium tuberculosis infection","volume":"12","author":"Jayaraman","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijtb.2023.05.012_bib19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3389\/fimmu.2019.01317","article-title":"The humoral immune response to BCG vaccination","volume":"10","author":"Tanner","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijtb.2023.05.012_bib20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/infdis\/jiw141","article-title":"Association of human antibodies to arabinomannan with enhanced Mycobacterial opsonophagocytosis and intracellular growth reduction","volume":"214","author":"Chen","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijtb.2023.05.012_bib21","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/CVI.00368-09","article-title":"Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis","volume":"17","author":"Henao-Tamayo","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"37","key":"10.1016\/j.ijtb.2023.05.012_bib22","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1016\/j.vaccine.2018.07.035","article-title":"Induction and maintenance of a phenotypically heterogeneous lung tissue-resident CD4+ T cell population following BCG immunisation","volume":"36","author":"Bull","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ijtb.2023.05.012_bib23","first-page":"53","article-title":"History of BCG vaccine","volume":"8","author":"Luca","year":"2013","journal-title":"Maedica"},{"issue":"8","key":"10.1016\/j.ijtb.2023.05.012_bib24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijtb.2023.05.012_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801180","article-title":"Microneedle-mediated vaccine delivery to the oral mucosa","volume":"8","author":"Creighton","year":"2019","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"10.1016\/j.ijtb.2023.05.012_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/sji.12351","article-title":"Immunization with single oral dose of alginate-encapsulated BCG elicits effective and long-lasting mucosal immune responses","volume":"82","author":"Hosseini","year":"2015","journal-title":"Scand J Immunol"},{"issue":"7788","key":"10.1016\/j.ijtb.2023.05.012_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature"},{"issue":"6152","key":"10.1016\/j.ijtb.2023.05.012_bib28","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1126\/science.1241800","article-title":"Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine","volume":"341","author":"Seder","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ijtb.2023.05.012_bib29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41385-018-0109-1","article-title":"Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1(+) KLRG1(-) CD4(+) T cells","volume":"12","author":"Bull","year":"2019","journal-title":"Mucosal Immunol"},{"issue":"43","key":"10.1016\/j.ijtb.2023.05.012_bib30","doi-asserted-by":"crossref","first-page":"6198","DOI":"10.1016\/j.vaccine.2012.07.061","article-title":"Protective efficacy of Mycobacterium indicus pranii against tuberculosis and underlying local lung immune responses in Guinea pig model","volume":"30","author":"Gupta","year":"2012","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ijtb.2023.05.012_bib31","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/iai.65.8.3317-3327.1997","article-title":"Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection","volume":"65","author":"Hernandez-Pando","year":"1997","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.ijtb.2023.05.012_bib32","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1086\/515024","article-title":"Cellular immune responses to mycobacteria in healthy and human immunodeficiency virus\u2013positive subjects in the United States after a five-dose schedule of Mycobacterium vaccae Vaccine","volume":"27","author":"von Reyn","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ijtb.2023.05.012_bib33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jmii.2014.03.005","article-title":"Recombinant tuberculosis vaccine AEC\/BC02 induces antigen-specific cellular responses in mice and protects Guinea pigs in a model of latent infection","volume":"48","author":"Lu","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"10.1016\/j.ijtb.2023.05.012_bib34","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.tube.2014.07.001","article-title":"Safety and immunogenicity of the M72\/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: an open-label randomized controlled trial","volume":"94","author":"Idoko","year":"2014","journal-title":"Tuberculosis"},{"issue":"2","key":"10.1016\/j.ijtb.2023.05.012_bib35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nm.4473","article-title":"Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine","volume":"24","author":"Hansen","year":"2018","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.ijtb.2023.05.012_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00014-18","article-title":"Identification and evaluation of novel protective antigens for the development of a candidate tuberculosis subunit vaccine","volume":"86","author":"Stylianou","year":"2018","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.ijtb.2023.05.012_bib37","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.vaccine.2015.01.058","article-title":"Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a Guinea pig model of tuberculosis","volume":"33","author":"Sander","year":"2015","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.ijtb.2023.05.012_bib38","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1073\/pnas.0409716102","article-title":"Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis","volume":"102","author":"Vergne","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"10.1016\/j.ijtb.2023.05.012_bib39","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/j.vaccine.2018.03.066","article-title":"Protective efficacy of recombinant BCG over-expressing protective, stage-specific antigens of mycobacterium tuberculosis","volume":"36","author":"Counoupas","year":"2018","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.ijtb.2023.05.012_bib40","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.vaccine.2012.12.053","article-title":"Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial","volume":"31","author":"Grode","year":"2013","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.ijtb.2023.05.012_bib41","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.micinf.2016.03.005","article-title":"Post-exposure vaccination with the vaccine candidate Bacillus Calmette\u2013Gu\u00e9rin\u0394ureC::hly induces superior protection in a mouse model of subclinical tuberculosis","volume":"18","author":"Gengenbacher","year":"2016","journal-title":"Microb Infect"},{"key":"10.1016\/j.ijtb.2023.05.012_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100313","article-title":"A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa","volume":"21","author":"Bekker","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"9493","key":"10.1016\/j.ijtb.2023.05.012_bib43","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ijtb.2023.05.012_bib44","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"Wang","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.ijtb.2023.05.012_bib45","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.3892\/mmr.2015.3770","article-title":"Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice","volume":"12","author":"Li","year":"2015","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.ijtb.2023.05.012_bib46","first-page":"34","article-title":"The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial","volume":"3","author":"Coler","year":"2018","journal-title":"Vaccines"},{"issue":"9","key":"10.1016\/j.ijtb.2023.05.012_bib47","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1128\/CVI.00372-14","article-title":"The ID93 tuberculosis vaccine candidate does not induce sensitivity to purified protein derivative","volume":"21","author":"Baldwin","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"12","key":"10.1016\/j.ijtb.2023.05.012_bib48","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.vaccine.2012.01.048","article-title":"A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity","volume":"30","author":"Hoft","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ijtb.2023.05.012_bib49","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection\u00a0before\u00a0and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"issue":"33","key":"10.1016\/j.ijtb.2023.05.012_bib50","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.vaccine.2015.06.051","article-title":"First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults","volume":"33","author":"Luabeya","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ijtb.2023.05.012_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176784","article-title":"Multi-subunit BCG booster vaccine GamTBvac: assessment of immunogenicity and protective efficacy in murine and Guinea pig TB models","volume":"12","author":"Tkachuk","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijtb.2023.05.012_bib52","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/vaccines7040166","article-title":"First-in-human trials of GamTBvac, a recombinant subunit tuberculosis vaccine candidate: safety and immunogenicity assessment","volume":"7","author":"Vasina","year":"2019","journal-title":"Vaccines"},{"issue":"12","key":"10.1016\/j.ijtb.2023.05.012_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168521","article-title":"Immunogenicity and protective efficacy of the DAR-901 booster vaccine in a murine model of tuberculosis","volume":"11","author":"Lahey","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijtb.2023.05.012_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217091","article-title":"CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: a randomized, placebo-controlled trial","volume":"14","author":"Masonou","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ijtb.2023.05.012_bib55","doi-asserted-by":"crossref","first-page":"e5930","DOI":"10.1371\/journal.pone.0005930","article-title":"Protection and polyfunctional T cells induced by Ag85B-TB10.4\/IC31\u00ae against Mycobacterium tuberculosis is highly dependent on the antigen dose","volume":"4","author":"Aagaard","year":"2009","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ijtb.2023.05.012_bib56","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.vaccine.2017.01.055","article-title":"Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: two phase I dose escalation trials","volume":"35","author":"Norrby","year":"2017","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.ijtb.2023.05.012_bib57","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2006.03.017","article-title":"The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and Guinea pigs","volume":"24","author":"Martin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ijtb.2023.05.012_bib58","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tube.2015.10.010","article-title":"MTBVAC vaccine is safe, immunogenic and\u00a0confers\u00a0protective efficacy against Mycobacterium\u00a0tuberculosis in newborn mice","volume":"96","author":"Aguilo","year":"2016","journal-title":"Tuberculosis"},{"issue":"12","key":"10.1016\/j.ijtb.2023.05.012_bib59","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S2213-2600(15)00435-X","article-title":"Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial","volume":"3","author":"Spertini","year":"2015","journal-title":"Lancet Respir Med"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570723000987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570723000987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T16:56:54Z","timestamp":1748019414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570723000987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":59,"alternative-id":["S0019570723000987"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2023.05.012","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An overview of the BCG vaccine and its future scope","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2023.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V. on behalf of Tuberculosis Association of India.","name":"copyright","label":"Copyright"}]}}